ENHANCEMENT OF TAXANE-BASED CHEMOTHERAPY BY A CDK1 ANTAGONIST
摘要
The present invention provides a combination therapy for inhibiting the growth of tumor, for treating cancer, and for inducing cell death. The therapy comprises the sequential administration of taxane and a CDK1 antagonist. The present invention also provides pharmaceutical compositions comprising taxane and a CDK1 antagonist and kits comprising taxane and CDK1 antagonist.
申请公布号
WO03039536(A1)
申请公布日期
2003.05.15
申请号
WO2002US34871
申请日期
2002.10.31
申请人
YALE UNIVERSITY;ALTIERI, DARIO, C.;O'CONNOR, DANIEL, S.